Cultured meat start-up Vow is reducing its workforce by 30%, resulting in 25 staff layoffs. CEO George Peppou cited slower-than-anticipated regulatory approvals as the reason for this “incredibly difficult decision.” Based in Sydney, Vow has secured over $50 million from notable investors, including Hostplus and Blackbird Ventures, to produce cultured meats—developed from cells in stainless-steel tanks rather than animals—with the aim of distributing them to upscale restaurants and supermarkets.
Vow’s innovative meat products have gained international attention, featuring items like foie gras made from Japanese quail cells and woolly mammoth meatballs created from DNA of ancient extinct species. Although some products have been served in restaurants in Hong Kong and Singapore, the company has not yet obtained regulatory approvals to sell in Australia, prompting the recent workforce reduction.
In a message to employees, referred to as “Vowzers,” Peppou explained that the layoffs were partly due to a “very challenging funding environment.” Alongside contributions from Hostplus and Blackbird Ventures, Vow has also attracted investments from Square Peg and the family office of Atlassian billionaire Mike Cannon-Brookes.
Peppou communicated to the team that Vow is finalizing a fundraising effort to ensure operational continuity into 2027. He emphasized that the company will focus on achieving product-market fit, enhancing manufacturing reliability, and obtaining regulatory approvals in new markets. Unfortunately, this means parting ways with several employees.
With nearly 100 staff members, primarily in Sydney, Vow has recruited engineers from SpaceX to pursue Peppou’s ambitious vision of establishing one of the largest food companies globally. He expressed that the decision to lay off staff was profoundly challenging and painful.
Peppou highlighted Vow’s pioneering role in an industry where many have faltered, noting that out of over 200 companies and more than $3 billion in investments, only three have received regulatory approvals to sell products worldwide, with Vow being one of them. He stated that Vow has successfully addressed the challenges of scale and market demand, and is leading in market access. However, the complexity and novelty of the regulatory process for cultured meat have delayed approvals longer than expected.
